Patents by Inventor Robert Foglesong

Robert Foglesong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080058395
    Abstract: This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. Also provided are methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein Q is a member selected from O, S, CR1 and N, X and Y are members independently selected from CR2, O, S, N and NR3.
    Type: Application
    Filed: July 2, 2007
    Publication date: March 6, 2008
    Applicant: SEPRACOR INC.
    Inventors: Michele Heffernan, James Dorsey, Qun Fang, Robert Foglesong, Seth Hopkins, Michael Jones, Steven Jones, Cyprian Ogbu, Joe Perales, Mustapha Soukri, Kerry Spear, Mark Varney
  • Publication number: 20080004328
    Abstract: This invention provides fused heterocycles having the formula: in which R1 is a member selected from the group consisting of H, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R2 is a member selected from the group consisting of H substituted or unsubstituted alkenyl, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R3is a member selected from the group consisting of H, C1-C6 substituted or unsubstituted alkyl, substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl. R4 is a member selected from OH and O?X+, in which X+ is positive ion which is a member selected from organic positive ions and inorganic positive ions. Substituted or unsubstituted arylalkyl and substituted or unsubstituted heteroarylalkyl moieties have the formula: in which Ar is a member selected from the group consisting of substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl.
    Type: Application
    Filed: August 3, 2007
    Publication date: January 3, 2008
    Applicant: SEPRACOR INC.
    Inventors: James Dorsey, Michele Heffernan, Qun Fang, Robert Foglesong, Seth Hopkins, Cyprian Ogbu, Mustapha Soukri, Kerry Spear
  • Publication number: 20080004327
    Abstract: This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein A is NH or S. Q is a member selected from CR1 and N. X and Y are members independently selected from O, S, CR2, N and NH. R1, R2 and R4 are members independently selected from H and F, provided that at least one member selected from R1, R2 and R4 is F. R6 is a member selected from O?X+ and OH, wherein X+ is a positive ion, which is a member selected from inorganic positive ions and organic positive ions.
    Type: Application
    Filed: July 2, 2007
    Publication date: January 3, 2008
    Applicant: SEPRACOR INC.
    Inventors: Michele Heffernan, Robert Foglesong, Seth Hopkins, Mustapha Soukri, Steven Jones, Kerry Spear, Mark Varney